Your browser doesn't support javascript.
loading
A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects.
Zhang, Tan; Chen, Guihong; Liu, Chang; Zu, Li'an; Wang, Qi; Wang, Yitong; Lv, Jie; An, Youzhong; Dong, Lihou; Cheng, Huiyang; Ren, Shengbin; Wang, Qian; Zheng, Qingshan; Song, Haifeng; Fang, Yi.
Afiliação
  • Zhang T; Department of Pharmacy, Peking University People's Hospital, Beijing, China.
  • Chen G; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical, Peking University, Beijing, China.
  • Liu C; Department of Pharmacy, Shenzhen Bao'an District Songgang People's Hospital, Shenzhen, China.
  • Zu L; Phase I Clinical Research Center, The Sixth Affiliated Hospital of Guangzhou Medical University Qingyuan People's Hospital, Guangdong, China.
  • Wang Q; Comprehensive Chemotherapy Ward, Peking University People's Hospital, Beijing, China.
  • Wang Y; Department of Pharmacy, Peking University People's Hospital, Beijing, China.
  • Lv J; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical, Peking University, Beijing, China.
  • An Y; Department of Pharmacy, Peking University People's Hospital, Beijing, China.
  • Dong L; Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical, Peking University, Beijing, China.
  • Cheng H; Department of Intensive Care Units, Peking University People's Hospital, Beijing, China.
  • Ren S; Department of Intensive Care Units, Peking University People's Hospital, Beijing, China.
  • Wang Q; Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, Beijing, China.
  • Zheng Q; Department of Clinical and Registration, Genor Biopharm Co., Ltd., Shanghai, China.
  • Song H; Department of Clinical and Registration, Genor Biopharm Co., Ltd., Shanghai, China.
  • Fang Y; Department of Pharmacy, Peking University People's Hospital, Beijing, China.
BioDrugs ; 33(1): 93-100, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30511316
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Infliximab Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Infliximab Idioma: En Ano de publicação: 2019 Tipo de documento: Article